2019/03/21 6:00 PM

NEOVACS TO PRESENT THE PRECLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID AT KEYSTONE CONGRESS: "Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions"

Information only available in PDF version.

This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: lJ1yYZVvYprFynFuYptlZpJlaJqVlWiZZWfLyGSZmJqWcJuUx2hpnJSZZm9onGtt
- Check this key: https://www.security-master-key.com.

Download

Back

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Regulated information

NEOVACS TO PRESENT THE PRECLINICAL RESULTS OF ITS THERAPEUTIC VACCINE CANDIDATE IL-4 / IL-13 KINOID AT KEYSTONE CONGRESS: "Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions"